Organ-Specific Screening for Protein Damage Using Magnetic Bead Bioreactors and LC-MS/MS

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Metabolite-protein adducts are crucial biomarkers for drug toxicity and disease.
• Existing methods for adduct detection are often time-consuming and low-throughput.
• Enzyme-mediated bioactivation plays a key role in forming reactive metabolites.

Purpose of the Study:

• To develop a fast, enzyme-multiplexed 96-well plate methodology for screening metabolite-protein adducts.
• To enable high-throughput analysis of reactive metabolite formation and protein adduction.
• To provide a versatile platform for assessing metabolic enzyme activity and adduct formation.

Main Methods:

• Utilized magnetic beads coated with metabolic enzymes (microsomes, supersomes) to generate reactive metabolites.
• Developed a multi-plate sample workup procedure for LC-MS/MS analysis.
• Employed model proteins (hGSTP, HSA, BSA) and acetaminophen metabolite (NAPQI) for method validation.

Main Results:

• Demonstrated efficient trapping of acetaminophen reactive metabolite NAPQI by model proteins.
• Identified human liver microsomes and CYP1A2 supersomes as having the highest bioactivation rates.
• Quantified adduct formation across multiple cysteine residues in hGSTP, HSA, and BSA.

Conclusions:

• The developed 96-well plate method offers a fast and efficient approach for enzyme-multiplexed screening of metabolite-protein adducts.
• This methodology has significant potential for high-throughput drug safety screening and biomarker discovery.
• The study highlights the utility of this platform for understanding metabolic bioactivation pathways.